Navigation Links
Novavax Appoints Stanley Erck to Board of Directors
Date:6/26/2009

ROCKVILLE, Md., June 26 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today the appointment of Stanley Erck to the company's Board of Directors. Mr. Erck has more than twenty five years of experience in the biotechnology and health-care industries and served most recently as President and Chief Executive Officer of Iomai Corporation, a developer of vaccines and immune system therapies that was acquired in 2008 by Intercell. Previously, Mr. Erck was President and Chief Executive Officer of Procept, a publicly traded immunology company, Vice President of Corporate Development at Integrated Genetics (now Genzyme), and in management positions at Baxter International. His appointment brings the number of Novavax board members to nine.

John Lambert, Chairman of the Board of Novavax, stated: "We are pleased to have Stanley Erck join our board and bring his pharmaceutical knowledge and many years of experience in vaccine development to our company. He has a strong record of achievement in building successful companies, a keen understanding of the market for infectious disease products and valuable experience in working with public health agencies. We welcome his anticipated contributions to our future success as we expand our pipeline of promising vaccine candidates."

Mr. Erck is also a Director of BioCryst Pharmaceuticals, MaxCyte, Inc. and MdBio Foundation. He received his undergraduate degree from the University of Illinois and his masters in business administration from the University of Chicago.

ABOUT NOVAVAX

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biotechnology company creating novel vaccines, including H1N1, to address a broad range of infec
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine
2. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2009
3. Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus
4. Novavax Reports First Quarter 2009 Financial Results
5. Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate
6. Novavax Announces Release Date of 2009 First Quarter, Financial Results and Investor Conference Call
7. Novavax Announces Early Retirement of $17 Million of Convertible Debt
8. NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains
9. Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India
10. Novavax Announces New Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call
11. Novavax Announces Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 softwa
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...ew method of obtaining marine microbe samples whil... has yielded an unexpected boon: the presence of m...act as switches to regulate gene expression in the...could only be studied in lab-cultured microorganis...ting may make it possible finally to learn on a br...
...ased biotech firm Replikins Ltd. ( www.replikins.c...nomic sequence data available and determined that ...rkedly, while its lethality will remain relatively...itative analysis of the most recent sequence data ...ory for published papers, showed an increase of 46...
...ip for Clear Health Communication at the National ...pients of the prestigious Pfizer Health Literacy i...r innovative and influential efforts in the Health... the Center for Communication in Healthcare at Nor..., and Dr. Rima Rudd, Senior Lecturer on Society, H...
Other Biology Technology:MIT reels in RNA surprise with microbial ocean catch 2MIT reels in RNA surprise with microbial ocean catch 3Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data 2Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data 3Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation 2Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation 3
(Date:12/3/2009)PHILADELPHIA Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal
(Date:12/3/2009)Coral reef fish can undergo a personality change in warmer water, according to an intriguing new study suggesting that climate change may make some species more aggressive. , Experiments with two spe
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Fish with attitude: Some like it hot 2CO2 levels rising in troposphere over rural areas 2IVANS Hit Experts Available To Discuss the Dept of HHS Recommendation Of 26amp 3B 238220 3BMeaningful Use 26amp 3B 238221 3B and How Potential Tight 49264 1IVANS Hit Experts Available To Discuss the Dept of HHS Recommendation Of 26amp 3B 238220 3BMeaningful Use 26amp 3B 238221 3B and How Potential Tight 49264 2IVANS Hit Experts Available To Discuss the Dept of HHS Recommendation Of 26amp 3B 238220 3BMeaningful Use 26amp 3B 238221 3B and How Potential Tight 49264 3MedNet Solutions Unveils New Naming and Functionality for its Flagship EDC eClinical Offering 12678 1MedNet Solutions Unveils New Naming and Functionality for its Flagship EDC eClinical Offering 12678 2Scientists sequence genome of the N2 fixing soil living bacterium Azotobacter vinelandii 8883 1Scientists sequence genome of the N2 fixing soil living bacterium Azotobacter vinelandii 8883 2Scientists sequence genome of the N2 fixing soil living bacterium Azotobacter vinelandii 8883 3
...tists at the Institute of Food Research have detec...lnerable to the development of tumours. , With s...echnology and Biological Sciences Research Council... these changes and delay or reverse the onset of c...lay a role in the very earliest stages of colorect...
...ssor James Whisstock has received the Commonwealth...and Medical Research. , Professor Whisstock was p...retary for Defence Support, Dr Mike Kelly on Thurs...Research dinner, one of the highlights of Medical ...tionally renowned scientist who has completed thei...
...BIA, Mo. At noon, it was black as night. It was M... judgment day was at hand. Accounts of that day, w...ude mentions of midday meals by candlelight, night...etals,and strange behavior from animals. The myste...he University of Missouri who say evidence from tr...
Other Biology News:'Addicted' cells provide early cancer diagnosis 2Monash researcher receives prestigious Commonwealth Health Minister's award 2Mystery of infamous 'New England Dark Day' solved by tree rings 2
Enzyme Characterization Service from ARVYS Proteins, Inc.
Yeast-GFP Collection from Invitrogen
Denhardt's solution from Sigma-Aldrich
Yeast-GFP 96-well Plates from Invitrogen
Biology Products: